1. Home
  2. DRVN vs BEAM Comparison

DRVN vs BEAM Comparison

Compare DRVN & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Driven Brands Holdings Inc.

DRVN

Driven Brands Holdings Inc.

HOLD

Current Price

$15.66

Market Cap

2.5B

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$27.60

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRVN
BEAM
Founded
1972
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Automotive Aftermarket
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.8B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
DRVN
BEAM
Price
$15.66
$27.60
Analyst Decision
Buy
Buy
Analyst Count
9
14
Target Price
$20.00
$46.00
AVG Volume (30 Days)
891.3K
2.2M
Earning Date
02-24-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,439,296,000.00
$55,701,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.27
$23.55
P/E Ratio
N/A
N/A
Revenue Growth
18.60
N/A
52 Week Low
$13.44
$13.53
52 Week High
$19.74
$36.44

Technical Indicators

Market Signals
Indicator
DRVN
BEAM
Relative Strength Index (RSI) 52.78 44.45
Support Level $15.05 $28.37
Resistance Level $16.30 $32.26
Average True Range (ATR) 0.55 2.72
MACD -0.05 -0.57
Stochastic Oscillator 49.25 1.83

Price Performance

Historical Comparison
DRVN
BEAM

About DRVN Driven Brands Holdings Inc.

Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: